CEO Mark Brandreth to leave RJAH for new role leading local health system

Release Date: 09/06/2021

CEO Mark Brandreth to leave RJAH for new role leading local health system

Mark Brandreth, Chief Executive of The Robert Jones and Agnes Hunt Orthopaedic Hospital (RJAH), is to leave the organisation to lead the development of integrated health services in Shropshire Telford & Wrekin (STW).
 
The experienced leader has come through a “rigorous and competitive” recruitment process to be named as Interim Accountable Officer for the STW Clinical Commissioning Group (CCG). He will also continue as Executive Lead for the STW Integrated Care System (ICS).
 
He will take up the joint role on Monday 2 August, at which point he will step down as Chief Executive of The Robert Jones and Agnes Hunt Orthopaedic Hospital (RJAH) – a role he has held for the last five years.
 
Mark has built a solid reputation for his work at RJAH – taking the Trust that was in breach of its licence with its regulator when he took over and rated ‘Requires Improvement’ by the Care Quality Commission to one which is now rated ‘Good’ overall and ‘Outstanding’ for care. The Trust has also consistently received feedback via the NHS Staff Survey and Adult Inpatient Survey during this period, which is amongst the very best in the NHS.
 
He also played a key role in the NHS response to the coronavirus pandemic, taking some time away from Shropshire last year to lead a number of national projects including the Nightingale Hospital programme.
 
Speaking to confirm his departure from the Oswestry-based hospital Trust, Mark said: “It has been a great honour be the Chief Executive of this world class hospital. I am very proud of what the staff have achieved over my time here. I am very proud of the care we provide to patients and as I have said many times, I believe we have the best staff in the NHS.

“The new role I am going into is that special job. It is an opportunity to lead a team working on the future of our health and care system here in Shropshire, Telford & Wrekin as we move towards establishing our Integrated Care System as a new NHS body. I am very fortunate that I will still be working closely with RJAH clinicians and leaders as part of developing the ICS.”
 
RJAH is immediately beginning the process of recruiting a new Chief Executive. It’s Chief Nurse, Stacey Keegan, will serve as Acting Chief Executive when Mark leaves.
 
Frank Collins, Chair of RJAH, added: “I would like to offer my congratulations to Mark, who deserves this opportunity.
 
“He has been at RJAH for over five years now, and, as we all know, has made a huge impact in that time - both at RJAH and, more recently, in the development of our ICS. His new role is a natural extension of that work.
 
“Recruitment of a successor begins immediately, and I am happy to appoint Stacey Keegan in the interim. It will be the second time that Stacey has assumed this position, having led the organisation in the early months of the coronavirus pandemic last year while Mark took up a national position to help shape the NHS response.
 
“She did a terrific job then, and I am delighted that she has agreed to take on the acting CEO role again. I know that we are in safe hands.”



Back to News